Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | jumonji domain containing protein | 0.009 | 0.2292 | 0.254 |
Loa Loa (eye worm) | hypothetical protein | 0.0136 | 0.4521 | 0.4836 |
Echinococcus multilocularis | chromobox protein 1 | 0.0075 | 0.1616 | 0.2133 |
Brugia malayi | jmjC domain containing protein | 0.0048 | 0.0305 | 0.0276 |
Schistosoma mansoni | chromobox protein | 0.0075 | 0.1616 | 0.1676 |
Echinococcus multilocularis | peregrin | 0.0042 | 0.0032 | 0.0042 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0057 | 0.0734 | 0.0547 |
Trichomonas vaginalis | chromobox protein, putative | 0.0045 | 0.0184 | 0.0969 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0199 | 0.7554 | 0.9967 |
Echinococcus multilocularis | fetal alzheimer antigen, falz | 0.0075 | 0.1612 | 0.2126 |
Schistosoma mansoni | methyl-cpg binding protein mbd | 0.0057 | 0.0734 | 0.0547 |
Loa Loa (eye worm) | PHD-finger family protein | 0.0069 | 0.1306 | 0.1374 |
Schistosoma mansoni | bromodomain containing protein | 0.0211 | 0.8126 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0128 | 0.4142 | 0.4429 |
Brugia malayi | Heterochromatin protein 1 | 0.0075 | 0.1616 | 0.1591 |
Echinococcus multilocularis | chromobox protein 1 | 0.0075 | 0.1616 | 0.2133 |
Schistosoma mansoni | hypothetical protein | 0.02 | 0.7579 | 0.93 |
Echinococcus granulosus | jumonji domain containing protein | 0.0048 | 0.0298 | 0.0353 |
Loa Loa (eye worm) | bromodomain containing protein | 0.0059 | 0.0832 | 0.0863 |
Echinococcus granulosus | chromobox protein 1 | 0.0075 | 0.1616 | 0.2099 |
Echinococcus granulosus | zinc finger protein | 0.0065 | 0.1137 | 0.1464 |
Echinococcus multilocularis | geminin | 0.02 | 0.7579 | 1 |
Schistosoma mansoni | methyl-cpg binding protein mbd | 0.0057 | 0.0734 | 0.0547 |
Echinococcus granulosus | Transcription factor JmjC domain containing protein | 0.0113 | 0.3401 | 0.4463 |
Echinococcus granulosus | methyl CpG binding domain protein 2 | 0.0057 | 0.0734 | 0.093 |
Trypanosoma brucei | ISWI complex protein | 0.0051 | 0.0453 | 0.5 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.012 | 0.3753 | 0.4951 |
Trypanosoma cruzi | ISWI complex protein | 0.0051 | 0.0453 | 0.5 |
Loa Loa (eye worm) | jmjC domain-containing protein | 0.0048 | 0.0305 | 0.0297 |
Trichomonas vaginalis | chromobox protein, putative | 0.0045 | 0.0184 | 0.0969 |
Schistosoma mansoni | hypothetical protein | 0.0051 | 0.0453 | 0.0189 |
Schistosoma mansoni | hypothetical protein | 0.02 | 0.7579 | 0.93 |
Loa Loa (eye worm) | hypothetical protein | 0.0236 | 0.9316 | 1 |
Trichomonas vaginalis | chromobox protein, putative | 0.0075 | 0.1616 | 1 |
Schistosoma mansoni | zinc finger protein | 0.0051 | 0.0453 | 0.0189 |
Schistosoma mansoni | zinc finger protein | 0.0065 | 0.1137 | 0.1063 |
Trypanosoma cruzi | ISWI complex protein | 0.0051 | 0.0453 | 0.5 |
Brugia malayi | Bromodomain containing protein | 0.0042 | 0.0032 | 0.0002 |
Echinococcus multilocularis | zinc finger protein | 0.0065 | 0.1137 | 0.15 |
Schistosoma mansoni | hypothetical protein | 0.0069 | 0.1306 | 0.1279 |
Schistosoma mansoni | chromobox protein | 0.0075 | 0.1616 | 0.1676 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.012 | 0.3753 | 0.493 |
Echinococcus multilocularis | methyl CpG binding domain protein 2 | 0.0057 | 0.0734 | 0.0968 |
Leishmania major | hypothetical protein, conserved | 0.0051 | 0.0453 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0057 | 0.0734 | 0.0758 |
Loa Loa (eye worm) | hypothetical protein | 0.0143 | 0.4826 | 0.5165 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0057 | 0.0734 | 0.0547 |
Echinococcus multilocularis | Transcription factor, JmjC domain containing protein | 0.0113 | 0.3401 | 0.4487 |
Echinococcus multilocularis | histone lysine methyltransferase setb histone lysine methyltransferase eggless | 0.0057 | 0.0734 | 0.0968 |
Brugia malayi | Bromodomain containing protein | 0.0128 | 0.4131 | 0.4113 |
Brugia malayi | PHD-finger family protein | 0.0083 | 0.199 | 0.1966 |
Echinococcus granulosus | chromobox protein 1 | 0.0075 | 0.1616 | 0.2099 |
Echinococcus granulosus | geminin | 0.02 | 0.7579 | 1 |
Echinococcus granulosus | fetal alzheimer antigen falz | 0.0075 | 0.1612 | 0.2093 |
Echinococcus granulosus | histone lysine methyltransferase setb | 0.0057 | 0.0734 | 0.093 |
Onchocerca volvulus | Heterochromatin protein 1 homolog | 0.0045 | 0.0184 | 1 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0199 | 0.7554 | 0.9966 |
Loa Loa (eye worm) | hypothetical protein | 0.0059 | 0.083 | 0.0862 |
Brugia malayi | jmjC domain containing protein | 0.0113 | 0.3401 | 0.3381 |
Echinococcus multilocularis | jumonji domain containing protein | 0.0048 | 0.0298 | 0.0394 |
Schistosoma mansoni | acetyl-CoA C-acetyltransferase | 0.0075 | 0.1612 | 0.167 |
Loa Loa (eye worm) | heterochromatin protein 1 | 0.0075 | 0.1616 | 0.1708 |
Echinococcus granulosus | lysine specific demethylase 5A | 0.0048 | 0.0305 | 0.0362 |
Loa Loa (eye worm) | jmjC domain-containing protein | 0.0071 | 0.1407 | 0.1483 |
Trichomonas vaginalis | chromobox protein, putative | 0.0075 | 0.1616 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
ED50 (functional) | = 20 mg kg-1 | Anticonvulsant activity in ip dosed albino CF1 mouse assessed as protection against maximal electroshock-induced seizures in presence of 50 miliamperes of electric current | ChEMBL. | 21861466 |
TD50 (ADMET) | = 67 mg kg-1 | Neurotoxicity in ip dosed albino CF1 mouse assessed as minimal motor coordination impairment by rotarod test | ChEMBL. | 21861466 |
Time (functional) | = 0.25 hr | Anticonvulsant activity in ip dosed albino CF1 mouse assessed as time of peak effect by maximal electroshock seizures test in presence of 50 miliamperes of electric current | ChEMBL. | 21861466 |
Time (ADMET) | = 0.25 hr | Neurotoxicity in ip dosed albino CF1 mouse assessed as time of peak effect by rotarod test | ChEMBL. | 21861466 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.